Arcadia Biosciences, Inc. (RKDA)
Stock Price:
$3.12 USD
0.19 (6.48%)
Updated November 24, 12:01 PM EST - Market open
Key Info
| Market Cap |
33.80M |
| Revenue (ttm) |
1.32M |
| Net Income (ttm) |
-19.80M |
| Shares Out |
10.83M |
| EPS (ttm) |
-2.12 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 24 |
| Last Price |
$3.12 |
| Previous Close |
$2.93 |
| Change ($) |
0.19 |
| Change (%) |
6.48% |
| Day's Open |
3.15 |
| Day's Range |
3.04 - 3.16 |
| Day's Volume |
245,379 |
| 52-Week Range |
2.30 - 6.63 |
More Stats
| Market Cap |
33.80M |
| Enterprise Value |
31.12M |
| Earnings Date (est) |
Mar 10, 2021 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
10.83M |
| Float |
9.16M |
| EPS (basic) |
-1.85 |
| EPS (diluted) |
-2.12 |
| FCF / Share |
-2.90 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
360,998 |
| Short Ratio |
2.74 |
| Short % of Float |
3.94% |
| Beta |
-0.63 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
25.60 |
| PB Ratio |
2.93 |
| Revenue |
1.32M |
| Operating Income |
-25.24M |
| Net Income |
-19.80M |
| Free Cash Flow |
-31.09M |
| Net Cash |
2.68M |
| Net Cash / Share |
0.25 |
| Gross Margin |
-516.21% |
| Operating Margin |
-1,912.27% |
| Profit Margin |
-1,499.80% |
| FCF Margin |
-2,355.53% |
| ROA |
-39.11% |
| ROE |
-159.67% |
| ROIC |
-94.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$11.33*
(263.14% upside)
Low
10.0
Current: $3.12
High
12.0
Target: 11.33
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Revenue | 1.17 | 1.46 | 4.03 | 3.19 | 5.41 | 6.98 | 6.48 |
| Revenue Growth | -20.15% | -63.64% | 26.29% | -41.12% | -22.46% | 7.78% | - |
| Gross Profit | 0.28 | 0.80 | 3.74 | 2.29 | 4.52 | 4.99 | 5.81 |
| Operating Income | -21.09 | -19.43 | -14.32 | -18.62 | -15.56 | -15.15 | -10.57 |
| Net Income | -28.81 | -13.48 | -15.71 | -19.62 | -17.96 | -18.34 | -13.20 |
| Shares Outstanding | 6.36 | 3.77 | 2.16 | 2.22 | 1.43 | 0.10 | 0.10 |
| Earnings Per Share | -4.53 | -3.58 | -7.28 | -8.85 | -14.60 | -214.20 | -128.60 |
| Operating Cash Flow | -17.20 | -13.63 | -13.97 | -17.06 | -15.11 | -14.79 | -9.75 |
| Capital Expenditures | -1.46 | -0.24 | -0.08 | -0.23 | -0.14 | -0.14 | -0.10 |
| Free Cash Flow | -18.66 | -13.87 | -14.04 | -17.29 | -15.25 | -14.93 | -9.85 |
| Cash & Equivalents | 25.33 | 21.82 | 13.02 | 50.56 | 50.24 | 16.57 | 2.84 |
| Total Debt | 2.24 | - | - | 25.13 | 24.93 | 14.48 | 14.49 |
| Net Cash / Debt | 23.09 | 21.82 | 13.02 | 25.43 | 25.31 | 2.10 | -11.66 |
| Assets | 32.57 | 24.02 | 16.57 | 56.57 | 74.24 | 24.89 | 9.54 |
| Liabilities | 24.25 | 11.21 | 8.56 | 34.38 | 34.02 | 26.77 | 26.84 |
| Book Value | 7.71 | 12.82 | 8.01 | 22.20 | 40.23 | -84.77 | -17.30 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Arcadia Biosciences, Inc. |
| Country |
United States |
| Employees |
41 |
| CEO |
Matthew T. Plavan |
Stock Information
| Ticker Symbol |
RKDA |
| Stock Exchange |
NASDAQ |
| Sector |
Basic Materials |
| Industry |
Agricultural Inputs |
| Unique Identifier |
NASDAQ: RKDA |
| IPO Date |
May 15, 2015 |
Description
Arcadia Biosciences, a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.